A Multidisciplinary Genitourinary Oncology Clinic provides a united assault in the treatment of genitourinary tract cancers. The clinic brings together healthcare providers from Urologic Surgery, Radiation Oncology (radiation therapy), and Oncology (chemotherapy). Patients are seen and case histories, medical records, and medical reports are reviewed. Urologic surgeons, radiation oncologists, and oncologists then strategically plot an individualized, united medical and/or surgical plan of care for each patient. To schedule an appointment, please call 402-559-4292.
MULTIDISCIPLINARY CLINIC SPECIALISTS |
|
UROLOGIC SURGERY Dr. LaGrange's practice is focused on minimally invasive surgery. He performs both standard laparoscopic and robot-assisted laparoscopic prostatectomy. He earned his BA and MD degrees from the University of Missouri-Kansas City. He completed his Urology residency at the University of Kentucky. |
|
UROLOGIC SURGERY Dr. Schober joined the Division of Urologic Surgery following completion of a two year Society of Urologic Oncology fellowship at the Fox Chase Cancer Center in Philadelphia, Pennsylvania. Dr. Schober’s focus is on urologic oncology, where he specializes in the cancers of the genitourinary tract, including kidney, adrenal gland, ureter, bladder, prostate, testes, and penis. He performs endoscopic, laparoscopic, robotic, and traditional open surgery. He is actively involved with clinical trials and research at the Fred & Pamela Buffet Cancer Center. |
|
RADIATION ONCOLOGY Prostate cancer is among Dr. Enke's clinical and research interests. He earned his MD at the University of Iowa and completed his Radiation Oncology residency at the Medical College of Wisconsin. |
|
RADIATION ONCOLOGY Prostate and urologic cancers are among Dr. Baine's clinical and research interests. He earned his MD, PhD in cancer biology, and completed his Radiation Oncology residency here at UNMC. |
|
ONCOLOGY Dr. Teply is an expert in the medical management of genitourinary cancers. His research focus includes novel therapies, optimal use of approved therapies, and clinical trials. After medical school at UNMC, he completed residency at the University of Michigan and his oncology fellowship at Johns Hopkins. |